Company Description
SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies.
The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities.
It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, healt
| Country | United States |
| IPO Date | Feb 9, 2010 |
| Industry | Asset Management |
| Sector | Financials |
| CEO | Bruce John Spohler |
Contact Details
Address: 500 Park Avenue, 3rd Floor New York, New York 10022 United States | |
| Phone | (212) 993-1670 |
| Website | slrinvestmentcorp.com |
Stock Details
| Ticker Symbol | SLRC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001418076 |
| CUSIP Number | 83413U100 |
| ISIN Number | US83413U1007 |
| Employer ID | 26-1381340 |
Key Executives
| Name | Position |
|---|---|
| Bruce John Spohler | Chief Operating Officer, Co-Chief Executive Officer and Interested Director |
| Michael Stuart Gross | Chairman, President and Co-Chief Executive Officer |
| Shiraz Y. Kajee CPA | Chief Financial Officer and Treasurer |
| Richard R. Pivirotto Jr. | Investor Relations |
| Guy Francis Talarico J.D. | Secretary and Chief Compliance Officer |
| Anthony Storino | Head of Healthcare Venture Lending |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2024 | N-2ASR | Filing |
| Mar 8, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Mar 8, 2024 | 40-17G | Filing |
| Feb 27, 2024 | 8-K | Current Report |
| Feb 27, 2024 | 10-K | Annual Report |
| Feb 9, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 16, 2023 | 8-K | Current Report |
| Nov 7, 2023 | 10-Q | Quarterly Report |
| Nov 7, 2023 | 8-K | Current Report |
| Oct 4, 2023 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |